Literature DB >> 12612220

Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns.

Robert I Koppel1, Charlotte M Druschel, Tonia Carter, Barry E Goldberg, Prabhu N Mehta, Rohit Talwar, Fredrick Z Bierman.   

Abstract

OBJECTIVE: To determine the sensitivity, specificity, predictive value, and accuracy of a program of pulse oximetry screening of asymptomatic newborns for critical congenital cardiovascular malformation (CCVM).
METHODS: Pulse oximetry was performed on asymptomatic newborns in the well-infant nurseries of 2 hospitals. Cardiac ultrasound was performed on infants with positive screens (saturation <or=95% at >24 hours). Data regarding true and false positives as well as negatives were collected and analyzed.
RESULTS: Oximetry was performed on 11 281 asymptomatic newborns, and 3 cases of CCVM were detected (total anomalous pulmonary venous return x2, truncus arteriosus). During the study interval, there were 9 live births of infants with CCVM from a group of 15 fetuses with CCVM detected by fetal echocardiography. Six infants with CCVM were symptomatic before screening. There was 1 false-positive screen. Two infants with negative screens were readmitted (coarctation, hypoplastic left pulmonary artery with aorto-pulmonary collaterals). Other cardiac diagnoses in the database search were nonurgent, including cases of patent foramen ovale, peripheral pulmonic stenosis, and ventricular septal defect. The prevalence of critical CCVM among all live births was 1 in 564 and among the screened population was 1 in 2256 (sensitivity: 60%; specificity: 99.95%; positive predictive value: 75%; negative predictive value: 99.98%; accuracy: 99.97%).
CONCLUSIONS: This screening test is simple, noninvasive, and inexpensive and can be administered in conjunction with state-mandated screening. The false-negative screen patients had lesions not amenable to detection by oximetry. The sensitivity, specificity, and predictive value in this population are satisfactory, indicating that screening should be applied to larger populations, particularly where lower rates of fetal detection result in increased CCVM prevalence in asymptomatic newborns.

Entities:  

Mesh:

Year:  2003        PMID: 12612220     DOI: 10.1542/peds.111.3.451

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  48 in total

1.  Combining pulse oximetry and clinical examination in screening for congenital heart disease.

Authors:  A F Bakr; H S Habib
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

2.  Failed detection of complex congenital heart disease (including double outlet right ventricle and total anomalous pulmonary venous return) by neonatal pulse oximetry screening.

Authors:  Patrick G Hetzel; René Glanzmann; Joëlle Günthard; Elisabeth Bruder; Esther Godi; Christoph Bührer
Journal:  Eur J Pediatr       Date:  2006-09-19       Impact factor: 3.183

3.  Chest radiography and the evaluation of the neonate for congenital heart disease.

Authors:  B Fonseca; R-K Chang; M Senac; G Knight; M S Sklansky
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 4.  Should pulse oximetry be used to screen for congenital heart disease?

Authors:  Pekka Valmari
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-05       Impact factor: 5.747

Review 5.  Accuracy of pulse oximetry in screening for congenital heart disease in asymptomatic newborns: a systematic review.

Authors:  Shakila Thangaratinam; Jane Daniels; Andrew K Ewer; Javier Zamora; Khalid S Khan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03-07       Impact factor: 5.747

6.  Screening newborns for congenital heart disease with pulse oximetry: survey of pediatric cardiologists.

Authors:  Ruey-Kang R Chang; Sandra Rodriguez; Thomas S Klitzner
Journal:  Pediatr Cardiol       Date:  2008-07-25       Impact factor: 1.655

7.  A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.

Authors:  Cora Peterson; Scott D Grosse; Jill Glidewell; Lorraine F Garg; Kim Van Naarden Braun; Mary M Knapp; Leslie M Beres; Cynthia F Hinton; Richard S Olney; Cynthia H Cassell
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

8.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 9.  Clinical Approach to a Neonate with Cyanosis.

Authors:  Saurabh Kumar Gupta
Journal:  Indian J Pediatr       Date:  2015-09-19       Impact factor: 1.967

10.  Congenital heart disease in India: a status report.

Authors:  Anita Saxena
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.